Halozyme Therapeutics, Inc. · NASDAQ:HALO
Appelhans Dannielle received 1,161 Halozyme Therapeutics, Inc. shares as an award (Form 4)
Traded Sep 1, 2026 · Filed Sep 2, 2026
On Sep 1, 2026, Appelhans Dannielle (Director) received 1,161 Halozyme Therapeutics, Inc. shares as an award, leaving 1,161 shares. Filed Sep 2, 2026 (Form 4).
- Awarded
- 1,161 shares
- Holding after
- 1,161 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 1, 2026 | Restricted Stock Units | Award | 1,161 | 1,161 | Direct |